ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions ...

Older adults were also more likely to arrive via emergency medical services (EMSs; 56.1% vs 34.0%; OR, 2.56; 95% CI, ...

Anaphylaxis is rare but serious — It’s a severe allergic reaction that can happen suddenly and progress quickly Triggers vary and can include foods, medications, insect stings and latex Epinephrine ...

A ratio-based tryptase formula for diagnosing pediatric anaphylaxis in the ED demonstrated higher diagnostic performance than ...

He told me that epinephrine is the medicine people use for a serious allergic reaction called anaphylaxis. It comes in an auto-injector, or EpiPen. “The interesting thing about epinephrine is that ...

Please provide your email address to receive an email when new articles are posted on . 44% of children with anaphylaxis received epinephrine before visiting the ED. There was no difference in ...

The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen) for anaphylaxis and other allergic reactions -- and I will be prescribing ...

Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...

Postoperative anaphylaxis after the use of neuromuscular blocking agents is often underreported; most survivors recover fully ...

“Outdated protocols” and a lack of patient education around anaphylaxis treatment can result in poor patient outcomes, Medscape Medical News reported Oct. 28. A survey of 96 patients and caregivers ...

"This collaboration represents a significant milestone for Nasus Pharma and for our NS002 program," said Dan Teleman, Chief Executive Officer of Nasus Pharma. "Through this collaboration, Nasus Pharma ...